Rational design of biologically active peptides: inhibition of T cell activation through interference with CD4 function. Transplant Int (2000) 13 [Suppl 1]: S306-S310. [electronic resource]
Producer: 20010329Description: 456-61 p. digitalISSN:- 0934-0874
- Animals
- CD4 Antigens -- chemistry
- CD4-Positive T-Lymphocytes -- drug effects
- Culture Media
- Cyclosporine -- pharmacology
- Dose-Response Relationship, Immunologic
- Drug Design
- Drug Synergism
- Graft Rejection -- prevention & control
- Humans
- Immunosuppressive Agents -- chemical synthesis
- Isoantigens -- immunology
- Lymphocyte Activation -- drug effects
- Lymphocyte Culture Test, Mixed
- Mitogens -- pharmacology
- Molecular Structure
- Muromonab-CD3 -- pharmacology
- Peptides, Cyclic -- chemical synthesis
- Phytohemagglutinins -- pharmacology
- Rats
- Signal Transduction -- drug effects
- Species Specificity
- Structure-Activity Relationship
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.